Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM Ter Braak, PW Plaisier… - European Journal of …, 2020 - Elsevier
Abstract Background In 20–25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

[PDF][PDF] Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 1854 - core.ac.uk
abstract Background: In 20e25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

[PDF][PDF] Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 1854 - pure.eur.nl
abstract Background: In 20e25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 2020 - repub.eur.nl
Background: In 20e25% of patients with biopsy-proven DCIS underestimation occurs.
Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

[PDF][PDF] Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - 2020 - specialistenasz.nl
abstract Background: In 20e25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

[PDF][PDF] Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 1854 - academia.edu
abstract Background: In 20e25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM Ter Braak… - … journal of surgical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background In 20-25% of patients with biopsy-proven DCIS underestimation occurs.
Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 2020 - ejso.com
Abstract Background In 20–25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).

S van Bekkum, BPM Ter Braak, PW Plaisier… - European Journal of …, 2020 - europepmc.org
Background In 20-25% of patients with biopsy-proven DCIS underestimation occurs.
Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …

[PDF][PDF] Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS)

S van Bekkum, BPM ter Braak, PW Plaisier… - European Journal of …, 1854 - pure.eur.nl
abstract Background: In 20e25% of patients with biopsy-proven DCIS underestimation
occurs. Sentinel lymph node biopsy (SLNB) is offered to patients with biopsy-proven ductal …